RxDoctor Payments Data

Karin Berg, MD

Anatomic Pathology · Memphis, TNNPI 1740220953

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Takeda Pharmaceuticals U.S.A., Inc. accounts for 70.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $148 and has fallen 81.2% since, to $28 in 2022.

$326in general payments, 2019–2025

Across 20 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$230
  • Ardelyx, Inc.$28
  • Alfasigma USA, Inc.$20
  • Daiichi Sankyo Inc.$20
  • Mauna Kea Technologies, Inc.$17
  • Merck$11

What the payments were for

  • Food & beverage$326100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$326 in reported general payments places this provider in the 65th percentile of 29 anatomic pathology providers in Tennessee.

See all anatomic pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$139,027
Medicare patients
850
Services billed
2,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →